Robert Lawrence Gottlieb, M.D. PH.D.
NPI 1386855922ActiveIndividual· Internal Medicine, Advanced Heart Failure and Transplant Cardiology· Dallas, TX
Internal Medicine, Advanced Heart Failure and Transplant Cardiology (M.D. PH.D.) in Dallas, Texas, trained at University of Colorado School of Medicine, Denver (class of 2005). Their prescriptions cost Medicare Part D more than their services did: $90,852 for 520 claims, against $29,014 paid for services in 2024. Alnylam Pharmaceuticals Inc. was the largest of 10 companies reporting payments in 2025, $146,316 in all, mostly speaking and faculty fees.
Overview
| NPI | 1386855922 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. PH.D. |
| Sole proprietor | No |
| NPI issued | May 25, 2007 |
| Last updated in NPPES | Mar 31, 2022 |
| Certified by provider | Mar 31, 2022 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology Primary | 207RA0001X | Q6197 | TX |
| Internal Medicine | 207R00000X | 2013-01783 | NC |
| Internal Medicine | 207R00000X | Q6197 | TX |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | 2013-01783 | NC |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | Q6197 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Cardiovascular Disease (Cardiology) (NC); Practitioner - Cardiovascular Disease (Cardiology) (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 95 |
|---|---|
| Services billed | 347 across 35 procedure codes |
| Paid by Medicare | $29,014 |
Part D prescriptions in 2024
| Prescriptions (claims) | 520 · 1,424 30-day fills |
|---|---|
| Patients | 50 |
| Total drug cost | $90,852 |
| Generic share | 90% of claims |
Education and affiliations
| Medical school | University of Colorado School of Medicine, Denver |
|---|---|
| Graduation year | 2005 |
| Medicare specialty | Cardiovascular Disease (Cardiology) |
Medical group
- Healthtexas Provider NetworkWaxahachie, TX · 2,697 clinicians
Hospital affiliations
Industry payments (Open Payments)
- 2025$146,316 · 127 payments from 10 companies
- 2024$82,894 · 87 payments from 10 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | $126,148 | 99 |
| Invivyd Inc | $19,340 | 15 |
| Abbott Laboratories | $312.54 | 4 |
| Alexion Pharmaceuticals, Inc. | $175.00 | 1 |
| Abiomed | $121.86 | 3 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$110,929 · 18 payments
- Travel and Lodging$16,413 · 44 payments
- Consulting Fee$15,425 · 3 payments
- Food and Beverage$3,549 · 62 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Dallas
- 1972846285
- 1588906986
- 1205045184
- 1033118278
- 1285699009
- 1700976974
- 1750511820
- 1912961145
- 1174849566
- 1043606502
- 1518353911
- 1326571902
All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Texas →